These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20145583)

  • 1. Interaction between the UCP2 -866 G>A polymorphism, diabetes, and beta-blocker use among patients with acute coronary syndromes.
    Beitelshees AL; Finck BN; Leone TC; Cresci S; Wu J; Province MA; Fabbrini E; Kirk E; Zineh I; Klein S; Spertus JA; Kelly DP
    Pharmacogenet Genomics; 2010 Apr; 20(4):231-8. PubMed ID: 20145583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The frequent UCP2 -866G>A polymorphism protects against insulin resistance and is associated with obesity: a study of obesity and related metabolic traits among 17 636 Danes.
    Andersen G; Dalgaard LT; Justesen JM; Anthonsen S; Nielsen T; Thørner LW; Witte D; Jørgensen T; Clausen JO; Lauritzen T; Holmkvist J; Hansen T; Pedersen O
    Int J Obes (Lond); 2013 Feb; 37(2):175-81. PubMed ID: 22349573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The common -866G/A polymorphism in the promoter region of the UCP-2 gene is associated with reduced risk of type 2 diabetes in Caucasians from Italy.
    Bulotta A; Ludovico O; Coco A; Di Paola R; Quattrone A; Carella M; Pellegrini F; Prudente S; Trischitta V
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1176-80. PubMed ID: 15562023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects.
    Sesti G; Cardellini M; Marini MA; Frontoni S; D'Adamo M; Del Guerra S; Lauro D; De Nicolais P; Sbraccia P; Del Prato S; Gambardella S; Federici M; Marchetti P; Lauro R
    Diabetes; 2003 May; 52(5):1280-3. PubMed ID: 12716765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes.
    D'Adamo M; Perego L; Cardellini M; Marini MA; Frontoni S; Andreozzi F; Sciacqua A; Lauro D; Sbraccia P; Federici M; Paganelli M; Pontiroli AE; Lauro R; Perticone F; Folli F; Sesti G
    Diabetes; 2004 Jul; 53(7):1905-10. PubMed ID: 15220218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association of functional UCP2 -866G/A and Ala55Val polymorphisms and type 2 diabetes in the Chinese population based on a case-control study and a meta-analysis.
    Qin LJ; Wen J; Qu YL; Huang QY
    Genet Mol Res; 2013 Sep; 12(3):3324-34. PubMed ID: 24065674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncoupling protein 2 -866G/A and uncoupling protein 3 -55C/T polymorphisms in young South African Indian coronary artery disease patients.
    Phulukdaree A; Moodley D; Khan S; Chuturgoon AA
    Gene; 2013 Jul; 524(2):79-83. PubMed ID: 23639961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of the -866A/55Val/Ins haplotype in the uncoupling protein 2 (UCP2) gene is associated with decreased UCP2 gene expression in human retina.
    de Souza BM; Assmann TS; Kliemann LM; Marcon AS; Gross JL; Canani LH; Crispim D
    Exp Eye Res; 2012 Jan; 94(1):49-55. PubMed ID: 22134120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. -866G/A and Ins/Del polymorphisms in UCP2 gene are associated with reduced short-term weight loss in patients who underwent Roux-en-Y gastric bypass.
    de Oliveira MS; Rodrigues M; Rossoni EA; Sortica DA; Rheinheimer J; Moehlecke M; Heredia MLDC; Horvath JDC; Kops NL; Trindade MRM; Viana LV; Leitão CB; Friedman R; Crispim D; de Souza BM
    Surg Obes Relat Dis; 2021 Jul; 17(7):1263-1270. PubMed ID: 33941479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The A allele of the UCP2 -866G/A polymorphism changes UCP2 promoter activity in HUVECs treated with high glucose.
    Crispim D; Rodrigues M; da Silva LPA; Bouças AP; Canani LH; Carlessi R; de Souza BM
    Mol Biol Rep; 2019 Oct; 46(5):4735-4741. PubMed ID: 31218541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association study of the -866G/A UCP2 gene promoter polymorphism with type 2 diabetes and obesity in a Tehran population: a case control study.
    Heidari J; Akrami SM; Heshmat R; Amiri P; Fakhrzadeh H; Pajouhi M
    Arch Iran Med; 2010 Sep; 13(5):384-90. PubMed ID: 20804304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in the uncoupling protein 2 and 3 genes and human performance.
    Dhamrait SS; Williams AG; Day SH; Skipworth J; Payne JR; World M; Humphries SE; Montgomery HE
    J Appl Physiol (1985); 2012 Apr; 112(7):1122-7. PubMed ID: 22241057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncoupling protein 2 promoter polymorphism -866G/A, central adiposity, and metabolic syndrome in Asians.
    Shen H; Qi L; Tai ES; Chew SK; Tan CE; Ordovas JM
    Obesity (Silver Spring); 2006 Apr; 14(4):656-61. PubMed ID: 16741267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the common -866G/A polymorphism of the uncoupling protein 2 gene on weight loss and body composition under sibutramine therapy in an obese Taiwanese population.
    Hsiao TJ; Wu LS; Hwang Y; Huang SY; Lin E
    Mol Diagn Ther; 2010 Apr; 14(2):101-6. PubMed ID: 20359253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An association between -866G/A polymorphism in the promoter of UCP2 and obesity: a meta-analysis.
    Liu L; Zhao X; Kang S; Zhang D
    Gene; 2013 Feb; 514(1):41-7. PubMed ID: 23147265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study between the -866G/A polymorphism in the promoter of uncoupling protein-2 gene and polycystic ovary syndrome.
    Kim JH; Li L; Yun JH; Choi BC; Baek KH
    Mol Med Rep; 2011; 4(4):747-51. PubMed ID: 21584501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans.
    Krempler F; Esterbauer H; Weitgasser R; Ebenbichler C; Patsch JR; Miller K; Xie M; Linnemayr V; Oberkofler H; Patsch W
    Diabetes; 2002 Nov; 51(11):3331-5. PubMed ID: 12401727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UCP2 -866G/A, Ala55Val and UCP3 -55C/T polymorphisms in association with obesity susceptibility - a meta-analysis study.
    Qian L; Xu K; Xu X; Gu R; Liu X; Shan S; Yang T
    PLoS One; 2013; 8(4):e58939. PubMed ID: 23560041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UCP2 and CFH Gene Variants with Genetic Susceptibility to Schizophrenia in Turkish Population.
    Nursal AF; Aydin PC; Pehlivan M; Sever U; Pehlivan S
    Endocr Metab Immune Disord Drug Targets; 2021; 21(11):2084-2089. PubMed ID: 33191890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The common G-866A polymorphism of the UCP2 gene and survival in diabetic patients following myocardial infarction.
    Palmer BR; Devereaux CL; Dhamrait SS; Mocatta TJ; Pilbrow AP; Frampton CM; Skelton L; Yandle TG; Winterbourn CC; Richards AM; Montgomery HE; Cameron VA
    Cardiovasc Diabetol; 2009 Jun; 8():31. PubMed ID: 19527523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.